SCOPE 2021: a new scorecard for osteoporosis in Europe

John A Kanis,Helena Johansson,Fredrik Borgström,Nicholas Norton,Nicholas C Harvey,Eugene V Mccloskey,Mattias Lorentzon,Trolle Jacobson,Carl Willers

doi:10.1007/s11657-020-00871-9

Abstract

SummaryThis scorecard summarises key indicators of the burden of osteoporosis and its management in the 27 member states of the European Union, as well as the UK and Switzerland. The resulting scorecard elements, assembled on a single sheet, provide a unique overview of osteoporosis in Europe.IntroductionThe scorecard for osteoporosis in Europe (SCOPE) is a project of the International Osteoporosis Foundation (IOF) that seeks to raise awareness of osteoporosis care in Europe. The aim of this project was to develop a scorecard and background documents to draw attention to gaps and inequalities in the provision of primary and secondary prevention of fractures due to osteoporosis.MethodsThe SCOPE panel reviewed the information available on osteoporosis and the resulting fractures for each of the 27 countries of the European Union plus the UK and Switzerland (termed EU27+2). The information obtained covered four domains: background information (e.g. the burden of osteoporosis and fractures), policy framework, service provision and service uptake, e.g. the proportion of men and women at high risk that do not receive treatment (the treatment gap).ResultsThere was a marked difference in fracture risk among the EU27+2 countries. Of concern was the marked heterogeneity in the policy framework, service provision and service uptake for osteoporotic fracture that bore little relation to the fracture burden. For example, despite the wide availability of treatments to prevent fractures, in the majority of the EU27+2, only a minority of patients at high risk receive treatment even after their first fracture. The elements of each domain in each country were scored and coded using a traffic light system (red, orange, green) and used to synthesise a scorecard. The resulting scorecard elements, assembled on a single sheet, provide a unique overview of osteoporosis in Europe.ConclusionsThe scorecard enables healthcare professionals and policy makers to assess their country’s general approach to the disease and provide indicators to inform the future provision of healthcare.

Highlights

The basis for scorecard for osteoporosis in Europe (SCOPE)SCOPE 2021 comprises a compendium of information available on the burden of osteoporosis and healthcare provision and uptake in the EU 27+2
Its history begins over 20 years ago with a series of regional audits of the International Osteoporosis Foundation (IOF) [1,2,3]
The information base has been supplemented with reports undertaken through the IOF on the burden of osteoporosis in the whole or selected countries of the EU, as well as the UK and Switzerland [4,5,6,7]

Summary

Introduction

The basis for SCOPESCOPE 2021 comprises a compendium of information available on the burden of osteoporosis and healthcare provision and uptake in the EU 27+2. The information base has been supplemented with reports undertaken through the IOF on the burden of osteoporosis in the whole or selected countries of the EU, as well as the UK and Switzerland [4,5,6,7]. Cost of illness studies can take a societal perspective (including all cost incurred directly or indirectly by society) or a payer perspective (usually includes all costs carried by the healthcare and social system). Both play an important role in the understanding of disease management and may aid decisions concerning societal resource allocation for research, development, and funding of new treatments.

Objectives

Methods

Results